Three members of the Department of Obstetrics and Gynecology were awarded a five-year grant through the National Institute of Child Health and Human Development’s Gynecologic Health and Disease Branch to establish a Harvard-wide Women’s Reproductive Health Research (WRHR) Program to promote the…
The Brigham’s Genital Tract Biology Lab, directed by Raina Fichorova, MD, PhD, distinguished chair of the Department of Obstetrics and Gynecology, earned accreditation from the College of American Pathologists (CAP) following a successful on-site inspection of the lab’s records, quality…
In the search of modifiable exposures during pregnancy that can improve birth outcomes and child health, a team of scientists from the NICHD-supported program Environmental Influences on Child Health Outcomes turn to the maternal diet. Link to YouTube
Brigham investigators find that distinct patterns of innate immunity can predict dysbiosis or infection in the female genital tract. Twitter.com/BrighamResearch PLoSONE Article: Aberrant Cervical Innate Immunity Predicts Onset of Dysbiosis and Sexually Transmitted Infections in Women of Reproductive Age
Raina Fichorova, MD, PhD: Innovative Reproductive Immunologist The Boston Lying-In laid the foundation of the Brigham as the first hospital in New England to provide a safe birthing place for women in 1832. Raina Fichorova June sunlight washes over the…
Raina Fichorova, MD, PhD, chief of the Division of Genital Tract Biology in the Department of Obstetrics and Gynecology, received a five-year, $4.1 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to…
Research in preclinical models suggests that recombinant molecule could act as a topical anti-HIV microbicide. A vaginal microbicide that could prevent sexual transmission of HIV-1 in women has tremendous potential for saving lives and helping staunch an epidemic. But the…
Raina Fichorova, MD, PhD, of the Department of Obstetrics and Gynecology, received a Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for the development of Sage Gel, a biome-friendly vaginal moisturizer to relieve genitourinary menopausal…
According to the World Health Organization, more than half of all married or in-union women of reproductive age use some form of contraception. Additionally, the number of women around the globe who either use contraception or have an unmet need…
Fairhaven Health has received a medical grant from a federally-funded agency for the development of Sage Gel, an isotonic biome-friendly vaginal moisturizer to relieve Genitourinary Menopausal Symptoms (GSM) for improved relief in postmenopausal women. The funding is part of the…